Cargando…
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
BACKGROUND: Elevated cerebrospinal fluid (CSF) concentrations of total tau (T-tau) and phosphorylated tau at Thr181 (P-tau181) protein are typical of Alzheimer’s disease (AD). However, the T-tau assay measures only the mid-region of the protein, while tau in CSF is instead composed of a series of fr...
Autores principales: | Cicognola, Claudia, Hansson, Oskar, Scheltens, Philip, Kvartsberg, Hlin, Zetterberg, Henrik, Teunissen, Charlotte E., Blennow, Kaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871566/ https://www.ncbi.nlm.nih.gov/pubmed/33557920 http://dx.doi.org/10.1186/s13195-020-00756-6 |
Ejemplares similares
-
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
por: Hanes, Jozef, et al.
Publicado: (2020) -
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
por: Cicognola, Claudia, et al.
Publicado: (2018) -
Untangling the association of amyloid-β and tau with synaptic and axonal loss
in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020) -
Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)